Enhancement of cerebral vasoreactivity and cognition by intranasal insulin in typ

鼻内胰岛素对典型患者脑血管反应性和认知的增强作用

基本信息

  • 批准号:
    7898116
  • 负责人:
  • 金额:
    $ 25.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Type 2 diabetes mellitus (T2DM) is a major risk factor for vascular dementia. DM alters insulin transport across blood-brain barrier affecting perfusion and neuronal function. Intranasal administration enables to effectively deliver insulin to the brain. Clinical studies demonstrated improvement of cognitive function and memory in healthy and cognitively impaired people. Our goal is to determine the acute effects of intranasal insulin on regional perfusion and cognition in older diabetic adults. We propose a pilot study to examine the effects of a single dose of intranasal insulin on regional vasoreactivity and cognitive functions in 30 subjects with T2DM and 30 healthy controls >50 years old using a double blinded, placebo-controlled, cross-over design. Aim 1: We will determine the acute effects of a single 40-IU dose of intranasal insulin vs. placebo on regional perfusion and vasoreactivity to CO2 challenge measured by 3-D continuous arterial spin labeling (CASL) MRI at 3 Tesla in the control and diabetic groups. We will use transcranial Doppler to determine effects on intranasal insulin vs. placebo on dynamic autoregulation based on measurements of beat-to-beat pressure-flow velocity relationship. Aim 2: We will determine whether intranasal insulin improves cognitive functioning including attention, memory and executive function in older diabetic patients as compared with placebo and the control group. This translational study will address an important area about the effects of intranasal insulin on cerebral blood flow regulation and cognition in older diabetic people that has not been studied. Intranasal insulin administration may provide a novel therapeutic target for prevention and treatment of microvascular disease and cerebrovascular complications of T2DM. If successful, this approach may have significant impact on clinical management of large population of older adults with T2DM. PUBLIC HEALTH RELEVANCE: Diabetes mellitus is a major risk factor for both large and small vessel atherosclerosis, strokes, and vascular dementia. This pilot study aims to determine the efficacy of intranasal insulin to improve cerebral vasoreactivity and to explore the effects on cognitive function in older diabetic adults. If proven effective, intranasal insulin may become a new preventive and therapeutic target for treatment of cerebromicrovascular disease in older diabetic patients.
描述(由申请人提供):2型糖尿病(T2 DM)是血管性痴呆的主要风险因素。DM改变胰岛素通过血脑屏障的转运,影响灌注和神经功能。鼻内给药能够有效地将胰岛素递送至大脑。临床研究表明,改善健康和认知受损的人的认知功能和记忆。我们的目标是确定鼻内胰岛素对老年糖尿病患者局部灌注和认知的急性影响。我们提出了一项初步研究,采用双盲、安慰剂对照、交叉设计,在30例年龄>50岁的T2 DM受试者和30例健康对照者中检查单剂量鼻内胰岛素对局部血管反应性和认知功能的影响。目标1:我们将在对照组和糖尿病组中通过3-D连续动脉自旋标记(CASL)MRI在3 T下测量40 IU单剂量鼻内胰岛素与安慰剂对CO2激发的局部灌注和血管反应性的急性影响。我们将使用经颅多普勒来确定鼻内胰岛素与安慰剂对基于心跳间压力-流速关系测量的动态自动调节的影响。目标二:我们将确定与安慰剂组和对照组相比,鼻内胰岛素是否能改善老年糖尿病患者的认知功能,包括注意力、记忆力和执行功能。这项转化研究将解决一个重要领域的影响鼻内胰岛素对脑血流调节和认知老年糖尿病患者尚未研究。鼻内胰岛素给药可能为防治2型糖尿病微血管病变和脑血管并发症提供新的治疗靶点。如果成功,这种方法可能对大量老年T2 DM患者的临床管理产生重大影响。 公共卫生关系: 糖尿病是大血管和小血管动脉粥样硬化、中风和血管性痴呆的主要危险因素。本初步研究旨在确定鼻内胰岛素改善老年糖尿病患者脑血管反应性的疗效,并探讨其对认知功能的影响。如果证实有效,鼻内胰岛素可能成为治疗老年糖尿病患者微血管疾病的新的预防和治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VERA NOVAK其他文献

VERA NOVAK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VERA NOVAK', 18)}}的其他基金

Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID)
鼻内胰岛素改善 2 型糖尿病记忆力 (MemAID)
  • 批准号:
    9284469
  • 财政年份:
    2015
  • 资助金额:
    $ 25.19万
  • 项目类别:
Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID)
鼻内胰岛素改善 2 型糖尿病记忆力 (MemAID)
  • 批准号:
    9096770
  • 财政年份:
    2015
  • 资助金额:
    $ 25.19万
  • 项目类别:
Enhancing cerebral vasoreativity & cognition by intranasal insulin in T2DM
增强脑血管反应性
  • 批准号:
    8049733
  • 财政年份:
    2010
  • 资助金额:
    $ 25.19万
  • 项目类别:
Cerebromicrovascular disease in elderly with diabetes
老年糖尿病患者的脑微血管疾病
  • 批准号:
    7915657
  • 财政年份:
    2009
  • 资助金额:
    $ 25.19万
  • 项目类别:
Cerebromicrovascular disease in elderly with diabetes
老年糖尿病患者的脑微血管疾病
  • 批准号:
    7526865
  • 财政年份:
    2009
  • 资助金额:
    $ 25.19万
  • 项目类别:
CEREBRAL VASOREGULATION IN ELDERLY WITH STROKE
中风老年人的脑血管调节
  • 批准号:
    7718890
  • 财政年份:
    2008
  • 资助金额:
    $ 25.19万
  • 项目类别:
CEREBRAL PERFUSION AND COGNITIVE DECLINE IN TYPE 2 DIABETES
2 型糖尿病的脑灌注和认知能力下降
  • 批准号:
    7718917
  • 财政年份:
    2008
  • 资助金额:
    $ 25.19万
  • 项目类别:
CEREBRAL VASOREGULATION IN DIABETES
糖尿病的脑血管调节
  • 批准号:
    7606925
  • 财政年份:
    2007
  • 资助金额:
    $ 25.19万
  • 项目类别:
CEREBRAL PERFUSION AND COGNITIVE DECLINE IN TYPE 2 DIABETES
2 型糖尿病的脑灌注和认知能力下降
  • 批准号:
    7606966
  • 财政年份:
    2007
  • 资助金额:
    $ 25.19万
  • 项目类别:
Dynamical Assessment of Cerebral Autoregulation
大脑自动调节的动态评估
  • 批准号:
    7220719
  • 财政年份:
    2007
  • 资助金额:
    $ 25.19万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了